The Hepatitis Prevention, Control, and Elimination Program in Mongolia - Элэг бүтэн Монгол үндэсний хѳтѳлбѳр (National program)

The Hepatitis Prevention, Control, and Elimination Program in Mongolia - Элэг бүтэн Монгол үндэсний хѳтѳлбѳр (National program)

Virus targets
Hepatitis B
Hepatitis C
Type
Testing and treatment implementation
Setting
National
Phase
Active
WHO region
Western Pacific Region
Target goal
Country
Mongolia
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Injection safety and infection control
Prevention mother-child transmission
Screening and diagnosis
Strategic data analysis
Treatment
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
All ages
Birth cohorts of adults
Blood transfusion recipients
Household contact(s)
Infants (less than one year of age)
Newborn (born in last 30 days)
Occupations with possible exposure
Pregnant women
Sexual contact(s)
Performance target
Blood safety
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Performance target additional info

90% reduction in incidence and mortality by 2030

Summary and objectives

In the third stage of development and implementation of the HPCE Program in Mongolia, the Onom Foundation anchored the program into the system of the Government of Mongolia by having the Parliament of Mongolia officially approve the HPCE Program into the 2016 - 2020 Action Plan of the Government of Mongolia on September 9, 2016. The MISSION 2020 of the HPCE Program is to eliminate HCV in Mongolia by 2020 and to significantly reduce cirrhosis and liver cancer mortalities, and these two overarching goals were explicitly included in the 2016 - 2020 Action Plan of the Government of Mongolia. The Government of Mongolia approved the detailed plan for the HPCE Program on April 12, 2017 using a blueprint that was developed by the Onom Foundation. In doing so, the Government of Mongolia allocated MNT226Billion or US$96MM for the HPCE Program through 2020, which is the largest amount of funding ever allocated for a national program. On May 5, 2017, the General Population Hepatitis Screening was launched to identify hepatitis infection status of every individual 15 years of age or older. Over 1 million people were screened for chronic hepatitis infections as of July of 2019. No-out-of-pocket-cost HCV treatment was initiated nationwide on December 28, 2017 thanks to subsidies from the Public Health Insurance Fund. In addition, the Public Health Insurance Fund provides two free-of-charge HCV and HBV viral load testing under the HPCE Program. Over 50 thousand HCV patients have been treated as of July of 2019. According to analysis of randomly selected HCV patients received treatment, SVR in real-life situations is around 98%. The HPCE Program in Mongolia is serving as a model for other countries in their fight against viral hepatitis.

The Onom Foundation, in partnership with the World Hepatitis Alliance, won 1st place in  Category 4: Sustainable Financing in the Coalition's first Hepatitis Elimination Video Contest in 2020

 

 

 

 

 

 

 

 

From the producers: “Mongolia has one of the highest burdens of liver cancer in the world mainly due to hepatitis. To combat this the the Onom Foundation mobilised patients to gain cross party support for an elimination plan funded by the government of Mongolia. ND, Chair of the Onom Foundation explains how this happened.”

 

Last updated